New Mesothelioma Study - Asbestos Related Cancer Update - Simpson Millar LLP Solicitors

A new study in the USA could provide renewed hope for victims of asbestos related cancer eg Mesothelioma.
By: Emma Costin, Partner Simpson Millar LLP Solicitors
 
Sept. 16, 2009 - PRLog -- The Dartmouth Medical School’s study may provide a new hope for patients facing the asbestos related cancer mesothelioma. The school which is based in New Hampshire, USA completed studies based on past work performed with methylthioadenosine phosphorylase (MTAP). A missing enzyme linked to several types of cancers including lung cancer, pancreatic cancer, Leukemia, Lymphoma and mesothelioma, researchers found that MTAP may be linked to the development of malignant tumors in those who lack the enzyme.

The study lead by Dr. Martin Lubin and Adam Lubin, researchers from the university, utilised two powerful chemical agents to form a treatment which may destroy tumours whilst protecting healthy cells.

The first agent, thioguanine, is a highly toxic drug that can damage both cancerous and healthy cells, whilst the other drug, fluorouracil, protects healthy tissues from the first agent’s toxicity. Both of these drugs are already in clinical use but are administered in low doses due to the high potency of the medications.

Although in its early stages, the study demonstrates the possibility of attacking tumors that are resistant to these drugs, whilst still protecting healthy tissue. Dr. Lubin believes that successful animal studies will lead to clinical use as soon as possible.

The condition of malignant mesothelioma typically develops after exposure to asbestos. When toxic asbestos fibres are inhaled, they may become lodged in organs or body cavities, causing inflammation or infection. Many patients do not demonstrate symptoms of the cancer for 20 to 50 years after initial exposure occurred, allowing mesothelioma to progress to later stages of development.  There is no cure for mesothelioma however treatment options are available such as radiation; chemotherapy and surgery are available to prolong the sufferers’ life.

If you have been diagnosed with mesothelioma and you believe you contracted this disease due to the negligence of a third party you could be entitled to compensation.  Give our occupational disease and illness solicitors a call on 0800 634 1632 or send your query via email using our online form (http://www.simpsonmillar.co.uk/ourfirm/contacts/enquiryfo...).

Useful info:

Mesothelioma background info - http://www.simpsonmillar.co.uk/services/disease_illness/m...

Mesothelioma Compensation Claims - http://www.simpsonmillar.co.uk/services/disease_illness/a...

# # #

About Simpson Millar LLP Solicitors: Our industrial disease team have been acting for clients for many years and have specialist skills in regard to asbestos compensation claims.

Simpson Millar LLP have been acting for client for over 150 years and have helped many assist consumers, businesses and trade unions and their members with their legal enquiries.

We are accredited with Investors in People and Lexcel quality standards.
End
Source:Emma Costin, Partner Simpson Millar LLP Solicitors
Email:***@simpsonmillar.co.uk Email Verified
Zip:LS1 2JG
Tags:Asbestos, Mesothelioma, Cancer, Solicitors, Lawyers, Compensation, Claims, Health
Industry:Health, Legal, Industrial
Location:England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Simpson Millar LLP PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share